Luyan Pharma Co.,Ltd.

Shenzhen Stock Exchange 002788.SZ

Luyan Pharma Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 85.40 M

Luyan Pharma Co.,Ltd. Cash and Short-Term Investments is USD 85.40 M for the year ending December 31, 2023, a -0.82% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Luyan Pharma Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 86.10 M, a 31.70% change year over year.
Luyan Pharma Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 65.38 M, a -28.32% change year over year.
Luyan Pharma Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 91.21 M, a 48.08% change year over year.
Luyan Pharma Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 61.60 M, a -18.02% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Shenzhen Stock Exchange: 002788.SZ

Luyan Pharma Co.,Ltd.

CEO	Mr. Jinxiang Wu
IPO Date	Feb. 18, 2016
Location	China
Headquarters	No. 1004, Anling Road
Employees	5,475
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.

Key trends

Past 5 years